Transparency

Grassley blasts CMS foot-dragging on Sunshine Act

November 01, 2011

The Centers for Medicare and Medicaid Services, now a month overdue to issue draft guidelines for reporting pharma-physician contacts as required under healthcare reform legislation, said the department is working on it, but offered nothing in the way of a timeline.
 

Piercing the veil, but missing the value of medicine's industry ties

September 08, 2011

ProPublica's Dollars for Docs database has grown richer in pharma company payments but falls short in putting context around those expenditures, say industry-side critics.
 

GSK paid $57 mil. to doctors for speaking and advising in '10

March 31, 2011

GlaxoSmithKline said Thursday that it paid more than 5,000 US healthcare professionals a total of $56.8 million last year for promotional talks or serving on advisory boards.
 

GSK values drive flips rep bonus incentives

January 25, 2011

The drug industry must move from a mindset that emphasizes compliance with regulations to one steeped in core values of integrity and transparency if it is to regain the public's trust, GSK's Dierdre Connelly said at a conference yesterday.
 

FDA details new transparency plans

May 20, 2010

For the second phase of FDA's transparency initiative, the agency unveiled 21 draft guidance proposals dealing with increased public disclosure of adverse events reports, drug evaluation procedures, and manufacturing inspections, among several other proposals.
 

In protecting market research, federal exclusion may not always apply

March 25, 2010

Thanks to the work of lobbyists, marketing research-related payments are explicitly excluded from Sunshine legislation enacted Tuesday as part of the healthcare overhaul. But the exclusion may not always apply.
 

WOMMA lays out disclosure guidelines for social media

February 17, 2010

Social media marketers should make it easy for consumers to consider the source when products are being discussed, according to new disclosure guidelines from the Word of Mouth Marketing Association (WOMMA).
 

Pharma marketing research gains tenuous hold in frosty Minnesota

February 02, 2010

The Minnesota pharmacy board maintained that it's legal to pay doctors to answer bona fide marketing surveys, but legislation being debated may keep the state a marketing research "dead zone," said one lobbyist.
 

GSK reveals speaker, consulting fees

December 15, 2009

GlaxoSmithKline said it paid nearly $15 million in fees in the second quarter to US healthcare professionals for speaking and consulting services.
 

Merck discloses a portion of US speaker fees

October 20, 2009

On Monday, Merck disclosed fees paid to US-based medical and scientific professionals who spoke at promotional medical education programs during the third quarter of 2009.
 

Healthcare reform bill clears House

July 15, 2009

The House of Representatives' version of the healthcare reform bill, dubbed the America's Affordable Health Choices Act of 2009, includes the provisions of the Physician Payment Sunshine Act, which would mandate sweeping transparency measures for pharmas.
 

MM&M Awards 2011 HIghlights

The Best MM&M Awards Ever!
 
Popular Topics
Adherence Advertising Approval Brand Corporate Reputation DDMAC Digital Direct To Consumer (DTC) DTC Facebook FDA Generic Guidance Launch Loyalty Program Magazine Major Statement Manufacturing Media Medical Education Off-label Online Promotion Social Media Television